Willis Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6M Sell
14,777
-6,149
-29% -$6.23M 0.74% 55
2025
Q4
$22.5M Buy
20,926
+1,156
+6% +$1.11M 1.16% 33
2025
Q3
$15.1M Buy
19,770
+10,314
+109% +$7.68M 0.83% 53
2025
Q2
$7.37M Buy
+9,456
New +$7.35M 0.43% 68
2022
Q4
Sell
-9,116
Closed -$2.95M 116
2022
Q3
$2.95M Sell
9,116
-1,100
-11% -$349K 0.21% 80
2022
Q2
$3.31M Sell
10,216
-39,800
-80% -$11.9M 0.2% 82
2022
Q1
$14.3M Sell
50,016
-1,181
-2% -$304K 0.76% 56
2021
Q4
$14.1M Sell
51,197
-814
-2% -$206K 0.74% 56
2021
Q3
$12M Sell
52,011
-62,100
-54% -$15.3M 0.69% 58
2021
Q2
$26.2M Sell
114,111
-29,800
-21% -$5.99M 1.55% 23
2021
Q1
$26.9M Sell
143,911
-16,100
-10% -$3.15M 1.63% 22
2020
Q4
$27M Buy
+160,011
New +$23.9M 1.85% 20
2020
Q3
Sell
-12,411
Closed -$2.04M 108
2020
Q2
$2.04M Sell
12,411
-20
-0.2% -$3.07K 0.16% 95
2020
Q1
$1.72M Sell
12,431
-194,080
-94% -$26.7M 0.14% 92
2019
Q4
$27.1M Sell
206,511
-41,500
-17% -$4.81M 1.76% 26
2019
Q3
$27.7M Buy
248,011
+116,090
+88% +$12.9M 1.86% 14
2019
Q2
$14.6M Buy
+131,921
New +$15.5M 0.99% 50
2018
Q3
Sell
-226,011
Closed -$19.3M 113
2018
Q2
$19.3M Sell
226,011
-19,970
-8% -$1.64M 1.42% 21
2018
Q1
$19M Buy
245,981
+14,400
+6% +$1.16M 1.47% 22
2017
Q4
$19.6M Sell
231,581
-32,169
-12% -$2.74M 1.37% 23
2017
Q3
$22.6M Buy
263,750
+6,800
+3% +$558K 1.63% 10
2017
Q2
$21.1M Buy
256,950
+750
+0.3% +$61.2K 1.6% 10
2017
Q1
$21.5M Sell
256,200
-55,600
-18% -$4.45M 1.62% 12
2016
Q4
$22.9M Buy
311,800
+68,800
+28% +$5.12M 1.71% 9
2016
Q3
$19.5M Sell
243,000
-8,700
-3% -$696K 1.56% 11
2016
Q2
$19.8M Buy
251,700
+21,000
+9% +$1.58M 1.69% 11
2016
Q1
$16.6M Buy
230,700
+22,700
+11% +$1.72M 1.46% 19
2015
Q4
$17.5M Buy
208,000
+6,700
+3% +$556K 1.59% 11
2015
Q3
$16.8M Buy
201,300
+300
+0.1% +$25.3K 1.65% 11
2015
Q2
$16.8M Sell
201,000
-43,400
-18% -$3.31M 1.59% 9
2015
Q1
$17.8M Sell
244,400
-400
-0.2% -$28.5K 1.65% 11
2014
Q4
$16.9M Sell
244,800
-14,100
-5% -$952K 1.58% 13
2014
Q3
$16.8M Sell
258,900
-16,800
-6% -$1.06M 1.77% 11
2014
Q2
$17.1M Sell
275,700
-16,470
-6% -$983K 1.67% 12
2014
Q1
$17.2M Sell
292,170
-2,300
-0.8% -$128K 1.74% 11
2013
Q4
$15K Buy
294,470
+55,800
+23% +$2.79M 0.7% 23
2013
Q3
$11.7M Hold
238,670
1.34% 33
2013
Q2
$11.7M Buy
+238,670
New +$13M 1.34% 33

Other funds holding LLY

Willis Investment Counsel's LLY Position: Q1 2026 in Review

Willis Investment Counsel reduced its Eli Lilly (LLY) stake by 29% in Q1 2026, selling an estimated $6.23M and leaving 14,777 shares worth $13.6M. The position accounts for 0.74% of the portfolio, ranked #55.

Willis Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. The position peaked at $27.7M in Q3 2019. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Willis Investment Counsel held 14,777 shares of Eli Lilly worth $13.6M as of Q1 2026.
  • Willis Investment Counsel sold 6,149 Eli Lilly shares in Q1 2026, an estimated $6.23M.
  • Eli Lilly made up 0.74% of Willis Investment Counsel's portfolio in Q1 2026, its #55 holding.
  • Willis Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
  • Willis Investment Counsel's Eli Lilly position peaked at $27.7M in Q3 2019.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Willis Investment Counsel's 13F filing for Q1 2026, filed 5 May 2026.